Transgenic mice overexpressing BAFF develop a hyper-IgA syndrome characterized by elevated serum IgA levels and IgA deposition in the glomeruli (Table 1 and Fig. 3d) [52]. This evidence concerns the gene CD79A and Down syndrome.